{"id":783009,"date":"2023-09-11T08:58:28","date_gmt":"2023-09-11T12:58:28","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/rite-aid-announces-availability-of-otc-narcan-nasal-spray-at-all-locations\/"},"modified":"2023-09-11T08:58:28","modified_gmt":"2023-09-11T12:58:28","slug":"rite-aid-announces-availability-of-otc-narcan-nasal-spray-at-all-locations","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/rite-aid-announces-availability-of-otc-narcan-nasal-spray-at-all-locations\/","title":{"rendered":"Rite Aid Announces Availability of OTC NARCAN\u00ae Nasal Spray at All Locations"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Rite Aid Announces Availability of OTC NARCAN<sup>\u00ae<\/sup> Nasal Spray at All Locations<\/b><\/p>\n<p class=\"bwalignc\"><i>NARCAN<\/i><sup>\u00ae<\/sup><i> Nasal Spray is now available without a prescription at all Rite Aid and Bartell Drugs locations nationwide and RiteAid.com<\/i><\/p>\n<p>PHILADELPHIA&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nRite Aid (NYSE: RAD) announced today that NARCAN<sup>\u00ae<\/sup> Nasal Spray, a medication used to reverse the effects of an opioid overdose, is available at all locations nationwide, including Bartell Drugs in the Pacific Northwest. NARCAN<sup>\u00ae<\/sup> Nasal Spray can be purchased over the counter without a prescription.<\/p>\n<p>\nNARCAN<sup>\u00ae<\/sup> Nasal Spray (naloxone HCl 4 mg) is a medication designed to rapidly reverse the effects of a life-threatening opioid emergency and is the standard treatment for opioid overdose. It is now FDA-approved for OTC use and is available for purchase at Rite Aid stores nationwide and online at RiteAid.com.<\/p>\n<p>\n\u201cBy making NARCAN<sup>\u00ae<\/sup> Nasal Spray easily accessible over the counter to Rite Aid customers, more people will have the ability to save a life,\u201d said Summer Kerley, Vice President, Clinical Services and Market Access Solutions for Rite Aid. \u201cWe encourage customers to ask their local Rite Aid pharmacist how they can be prepared to reverse an opioid emergency.\u201d<\/p>\n<p>\nEach carton of NARCAN<sup>\u00ae<\/sup> Nasal Spray contains two single-dose devices. Each device contains one dose of medicine. The carton is readily available on shelves and at the pharmacy counter at Rite Aid stores and is priced at $45.99.<\/p>\n<p><b>About Rite Aid Corporation<\/b><\/p>\n<p>\nRite Aid is a full-service pharmacy that improves health outcomes. Rite Aid is defining the modern pharmacy by meeting customer needs with a wide range of vehicles that offer convenience, including retail and delivery pharmacy, as well as services offered through our wholly owned subsidiaries, Elixir, Bartell Drugs and Health Dialog. Elixir, Rite Aid\u2019s pharmacy benefits and services company, consists of accredited mail and specialty pharmacies, prescription discount programs and an industry leading adjudication platform to offer superior member experience and cost savings. Health Dialog provides healthcare coaching and disease management services via live online and phone health services. Regional chain Bartell Drugs has supported the health and wellness needs in the Seattle area for more than 130 years. Rite Aid employs more than 6,300 pharmacists and operates more than 2,300 retail pharmacy locations across 17 states. For more information, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.riteaid.com%2F&amp;esheet=53551449&amp;newsitemid=20230911566863&amp;lan=en-US&amp;anchor=www.riteaid.com&amp;index=1&amp;md5=2d1e36075ecd29e291898189682cb151\">www.riteaid.com<\/a>.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230911566863r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20230911566863\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20230911566863\/en\/<\/a><\/span><\/p>\n<p>\nMEDIA:<br \/>\n<br \/>Catherine Carter<br \/>\n<br \/>717-975-5718<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:Press@RiteAid.com\">Press@RiteAid.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> Pennsylvania United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Pharmaceutical Other Retail General Health Health Online Retail Discount\/Variety Retail Other Health<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230911566863\/en\/801162\/3\/RAD-Logo-PMS.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Rite Aid Announces Availability of OTC NARCAN\u00ae Nasal Spray at All Locations NARCAN\u00ae Nasal Spray is now available without a prescription at all Rite Aid and Bartell Drugs locations nationwide and RiteAid.com PHILADELPHIA&#8211;(BUSINESS WIRE)&#8211; Rite Aid (NYSE: RAD) announced today that NARCAN\u00ae Nasal Spray, a medication used to reverse the effects of an opioid overdose, is available at all locations nationwide, including Bartell Drugs in the Pacific Northwest. NARCAN\u00ae Nasal Spray can be purchased over the counter without a prescription. NARCAN\u00ae Nasal Spray (naloxone HCl 4 mg) is a medication designed to rapidly reverse the effects of a life-threatening opioid emergency and is the standard treatment for opioid overdose. It is now FDA-approved for OTC use and is available for &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/rite-aid-announces-availability-of-otc-narcan-nasal-spray-at-all-locations\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Rite Aid Announces Availability of OTC NARCAN\u00ae Nasal Spray at All Locations&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-783009","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Rite Aid Announces Availability of OTC NARCAN\u00ae Nasal Spray at All Locations - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/rite-aid-announces-availability-of-otc-narcan-nasal-spray-at-all-locations\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rite Aid Announces Availability of OTC NARCAN\u00ae Nasal Spray at All Locations - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Rite Aid Announces Availability of OTC NARCAN\u00ae Nasal Spray at All Locations NARCAN\u00ae Nasal Spray is now available without a prescription at all Rite Aid and Bartell Drugs locations nationwide and RiteAid.com PHILADELPHIA&#8211;(BUSINESS WIRE)&#8211; Rite Aid (NYSE: RAD) announced today that NARCAN\u00ae Nasal Spray, a medication used to reverse the effects of an opioid overdose, is available at all locations nationwide, including Bartell Drugs in the Pacific Northwest. NARCAN\u00ae Nasal Spray can be purchased over the counter without a prescription. NARCAN\u00ae Nasal Spray (naloxone HCl 4 mg) is a medication designed to rapidly reverse the effects of a life-threatening opioid emergency and is the standard treatment for opioid overdose. It is now FDA-approved for OTC use and is available for &hellip; Continue reading &quot;Rite Aid Announces Availability of OTC NARCAN\u00ae Nasal Spray at All Locations&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/rite-aid-announces-availability-of-otc-narcan-nasal-spray-at-all-locations\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-11T12:58:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230911566863r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rite-aid-announces-availability-of-otc-narcan-nasal-spray-at-all-locations\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rite-aid-announces-availability-of-otc-narcan-nasal-spray-at-all-locations\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Rite Aid Announces Availability of OTC NARCAN\u00ae Nasal Spray at All Locations\",\"datePublished\":\"2023-09-11T12:58:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rite-aid-announces-availability-of-otc-narcan-nasal-spray-at-all-locations\\\/\"},\"wordCount\":429,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rite-aid-announces-availability-of-otc-narcan-nasal-spray-at-all-locations\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230911566863r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rite-aid-announces-availability-of-otc-narcan-nasal-spray-at-all-locations\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rite-aid-announces-availability-of-otc-narcan-nasal-spray-at-all-locations\\\/\",\"name\":\"Rite Aid Announces Availability of OTC NARCAN\u00ae Nasal Spray at All Locations - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rite-aid-announces-availability-of-otc-narcan-nasal-spray-at-all-locations\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rite-aid-announces-availability-of-otc-narcan-nasal-spray-at-all-locations\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230911566863r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2023-09-11T12:58:28+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rite-aid-announces-availability-of-otc-narcan-nasal-spray-at-all-locations\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rite-aid-announces-availability-of-otc-narcan-nasal-spray-at-all-locations\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rite-aid-announces-availability-of-otc-narcan-nasal-spray-at-all-locations\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230911566863r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230911566863r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rite-aid-announces-availability-of-otc-narcan-nasal-spray-at-all-locations\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rite Aid Announces Availability of OTC NARCAN\u00ae Nasal Spray at All Locations\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rite Aid Announces Availability of OTC NARCAN\u00ae Nasal Spray at All Locations - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/rite-aid-announces-availability-of-otc-narcan-nasal-spray-at-all-locations\/","og_locale":"en_US","og_type":"article","og_title":"Rite Aid Announces Availability of OTC NARCAN\u00ae Nasal Spray at All Locations - Market Newsdesk","og_description":"Rite Aid Announces Availability of OTC NARCAN\u00ae Nasal Spray at All Locations NARCAN\u00ae Nasal Spray is now available without a prescription at all Rite Aid and Bartell Drugs locations nationwide and RiteAid.com PHILADELPHIA&#8211;(BUSINESS WIRE)&#8211; Rite Aid (NYSE: RAD) announced today that NARCAN\u00ae Nasal Spray, a medication used to reverse the effects of an opioid overdose, is available at all locations nationwide, including Bartell Drugs in the Pacific Northwest. NARCAN\u00ae Nasal Spray can be purchased over the counter without a prescription. NARCAN\u00ae Nasal Spray (naloxone HCl 4 mg) is a medication designed to rapidly reverse the effects of a life-threatening opioid emergency and is the standard treatment for opioid overdose. It is now FDA-approved for OTC use and is available for &hellip; Continue reading \"Rite Aid Announces Availability of OTC NARCAN\u00ae Nasal Spray at All Locations\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/rite-aid-announces-availability-of-otc-narcan-nasal-spray-at-all-locations\/","og_site_name":"Market Newsdesk","article_published_time":"2023-09-11T12:58:28+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230911566863r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rite-aid-announces-availability-of-otc-narcan-nasal-spray-at-all-locations\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rite-aid-announces-availability-of-otc-narcan-nasal-spray-at-all-locations\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Rite Aid Announces Availability of OTC NARCAN\u00ae Nasal Spray at All Locations","datePublished":"2023-09-11T12:58:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rite-aid-announces-availability-of-otc-narcan-nasal-spray-at-all-locations\/"},"wordCount":429,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rite-aid-announces-availability-of-otc-narcan-nasal-spray-at-all-locations\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230911566863r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rite-aid-announces-availability-of-otc-narcan-nasal-spray-at-all-locations\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/rite-aid-announces-availability-of-otc-narcan-nasal-spray-at-all-locations\/","name":"Rite Aid Announces Availability of OTC NARCAN\u00ae Nasal Spray at All Locations - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rite-aid-announces-availability-of-otc-narcan-nasal-spray-at-all-locations\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rite-aid-announces-availability-of-otc-narcan-nasal-spray-at-all-locations\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230911566863r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2023-09-11T12:58:28+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rite-aid-announces-availability-of-otc-narcan-nasal-spray-at-all-locations\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/rite-aid-announces-availability-of-otc-narcan-nasal-spray-at-all-locations\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rite-aid-announces-availability-of-otc-narcan-nasal-spray-at-all-locations\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230911566863r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230911566863r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rite-aid-announces-availability-of-otc-narcan-nasal-spray-at-all-locations\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Rite Aid Announces Availability of OTC NARCAN\u00ae Nasal Spray at All Locations"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/783009","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=783009"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/783009\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=783009"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=783009"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=783009"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}